(L-R) Professor Michael Heneka, Director at the at the Luxembourg Centre for Systems Biomedicine; Professor Giovanni Frisoni, Head of European Scientific Committee at the Alzheimer Research Foundation;
Credit: University of Luxembourg
On Thursday 26 March 2026, the University of Luxembourg (Uni.lu) reported that Professor Michael Heneka was awarded the European Grand Prize for Research 2026 by the Alzheimer Research Foundation.
The award was presented on Tuesday 17 March 2026 during the opening ceremony of the AD/PD™ International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders, held in Copenhagen.
According to Uni.lu, this prestigious prize rewards a researcher recognised within the scientific community for their contributions and impact in the field of Alzheimer’s disease research. The award is accompanied by a grant that will further support research on the pathogenesis of Alzheimer’s disease at the Luxembourg Centre for Systems Biomedicine (LCSB) at the University of Luxembourg.
The Alzheimer Research Foundation is the leading funder of research on Alzheimer’s and related diseases in France. It supports projects combining innovation and scientific excellence, led by French and European researchers, with a focus on preclinical and clinical research aimed at improving prevention and diagnosis, as well as developing effective treatments.
Professor Bruno Dubois, co-founder of the foundation, and Professor Giovanni Frisoni, head of its European Scientific Committee, presented the award to Professor Michael Heneka, highlighting his work on the interplay between the nervous and immune systems, now a key area of research in neurodegenerative diseases.
“I am deeply honoured to receive the European Grand Prize for Research 2026. It is overwhelming to receive such an outstanding international recognition. This prize will significantly contribute to our ongoing research on the pathogenesis of Alzheimer disease in Luxembourg,” Professor Michael Heneka, LCSB Director.
